Jade Biosciences, Inc. · NASDAQ:JBIO
Ra Capital Management, L.P. reported a 7.00% stake in Jade Biosciences, Inc. (Schedule 13G)
Event Oct 8, 2025 · Filed Oct 16, 2025
Ra Capital Management, L.P. reported a 7.00% stake in Jade Biosciences, Inc., 3,214,969 shares, as a passive investor on Oct 8, 2025. Filed Oct 16, 2025 (Schedule 13G).
- Stake
- 7.00%
- Shares
- 3,214,969
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 7.00% | 3,214,969 |
| Peter Kolchinsky | 7.00% | 3,214,969 |
| Rajeev Shah | 7.00% | 3,214,969 |
| RA Capital Healthcare Fund, L.P. | 7.00% | 3,214,969 |
Source
Related
- Jade Biosciences, Inc.
- Ra Capital Management, L.P.
- Jade Biosciences, Inc. shareholders
- Schedule 13D/A · Ra Capital Management, L.P. · Apr 30, 2025
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026